GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 49.13%
This Quarter Est. Return
1 Year Est. Return
+49.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$276M
AUM Growth
-$11.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$13.1M
2
+$9.25M
3
+$8.12M
4
JANX icon
Janux Therapeutics
JANX
+$6.36M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$5.2M

Top Sells

1
+$17M
2
+$11.7M
3
+$8.65M
4
PCVX icon
Vaxcyte
PCVX
+$8M
5
SLNO icon
Soleno Therapeutics
SLNO
+$7.57M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANTX icon
51
AN2 Therapeutics
ANTX
$30.4M
– –
-219,331
ARWR icon
52
Arrowhead Research
ARWR
$7.52B
– –
-35,000
BHVN icon
53
Biohaven
BHVN
$1.26B
– –
-490,000
CABA icon
54
Cabaletta Bio
CABA
$235M
– –
-370,899
CTMX icon
55
CytomX Therapeutics
CTMX
$696M
– –
-300,000
CYTK icon
56
Cytokinetics
CYTK
$8.27B
– –
-33,200
ELEV
57
DELISTED
Elevation Oncology
ELEV
– –
-600,000
KRYS icon
58
Krystal Biotech
KRYS
$6.23B
– –
-8,500
MGNX icon
59
MacroGenics
MGNX
$93M
– –
-150,000
NTLA icon
60
Intellia Therapeutics
NTLA
$1.01B
– –
-25,000
PMVP icon
61
PMV Pharmaceuticals
PMVP
$69.2M
– –
-375,000
PTCT icon
62
PTC Therapeutics
PTCT
$6.62B
– –
-19,000
RAPT icon
63
RAPT Therapeutics
RAPT
$899M
– –
0
SGMT icon
64
Sagimet Biosciences
SGMT
$223M
– –
-225,000
WVE icon
65
Wave Life Sciences
WVE
$1.26B
– –
-200,000
XBI icon
66
State Street SPDR S&P Biotech ETF
XBI
$8.02B
– –
0
ITCI
67
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-10,000
RVNC
68
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-225,000
ACAD icon
69
Acadia Pharmaceuticals
ACAD
$4.19B
– –
-225,000
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$61.1B
– –
-22,500
1 2
3